Tourmaline Bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $2,276 |
Gross Profit | -10 | -10 | 1,138 |
EBITDA | -21,971 | -17,507 | -7,105 |
EBIT | -21,981 | -17,517 | -6,000 |
Net Income | -17,487 | -13,311 | 2,126 |
Net Change In Cash | 0 | 0 | 2,276 |
Free Cash Flow | -18,007 | -14,923 | 11,020 |
Cash | 70,148 | 98,286 | 140,726 |
Basic Shares | 25,724 | 24,082 | 16,003 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -33 | -6 |
EBITDA | -45,376 | -19,695 |
EBIT | -45,409 | -19,701 |
Net Income | -42,124 | -19,701 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -28,137 | -11,526 |
Cash | 140,726 | 8,258 |
Basic Shares | 4,747 | 20,336 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.78 |
2024-06-30 | -$0.68 |
2024-03-31 | -$0.55 |
2023-12-31 | -$0.81 |
